BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PDX1
,
Angiogenesis
,
Influenza
,
Kidney
,
Amniocentesis
,
Cisplatin
,
rs2300478
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
dihydroergocryptine
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Prescription of ergot derivatives for lactation inhibition in France: Current practices].
Bioequivalence of a novel high-dose oral formulation of alpha-dihydroergocryptine.
Effect of alpha dihydroergocryptine in patients with fibrocystic breast disease].
Identification and human pharmacokinetics of dihydroergotoxine metabolites in man: preliminary resul…
Alpha-dihydroergocryptine in the long-term therapy of Parkinson's disease.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Association Between Dopamine Agonists and Cardiac Valvulopathy, Fibrosis and Other Cardiopulmona…
Deep Brain Stimulation for Parkinson's Disease: Probabilistic STN Targeting Under General Anaesthesi…
Single Blind Study of Ergoloid Mesylates, 5-HTP and the Combination in Adult Males With Fragile X Sy…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ